IP-2018

N/A

Report date: 2022/11/20 14:05:55
NME

Base Information

Drug NameIP-2018
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitors
TargetsDopamine transporter
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInitiator Pharma
China Registration ClassN/A

Develop Information

Active CompaniesInitiator Pharma
Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A